Bone marrow-derived mesenchymal stem cells and their conditioned medium attenuate fibrosis in an irreversible model of unilateral ureteral obstruction

Cell Transplantation

Volumn 24, Issue 12, 2015, Pages 2657-2666

  da Silva, Andrei F ^a   Silva, Kleiton ^a   Reis, Luciana A ^a   Teixeira, Vicente P C ^a   Schor, Nestor ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Conditioned medium (CM); Fibrosis; Mesenchymal stem cells (MSCs); Repair; Unilateral ureteral obstruction (UUO)

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE 3; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; CYCLINE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACTIN; COLLAGEN TYPE I, ALPHA 1 CHAIN; CONDITIONED MEDIUM; SMOOTH MUSCLE ACTIN, RAT; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; KIDNEY FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; ANIMAL; BIOLOGICAL THERAPY; BIOSYNTHESIS; BONE MARROW CELL; CELL CULTURE; CONDITIONED MEDIUM; CYTOLOGY; DISEASE MODEL; FIBROSIS; IMMUNOLOGY; KIDNEY TUBULE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHARMACOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; URETERAL OBSTRUCTION; WISTAR RAT;

ACTINS; ANIMALS; BONE MARROW CELLS; CASPASE 3; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; COLLAGEN TYPE I; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; FIBROSIS; INFLAMMATION; KIDNEY TUBULES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, WISTAR; RENAL INSUFFICIENCY, CHRONIC; TUMOR NECROSIS FACTOR-ALPHA; URETERAL OBSTRUCTION;

EID: 84942038168     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368915X687534     Document Type: Article

References (35)

1. Asanuma, H.; Vanderbrink, B. A.; Campbell, M. T.; Hile, K. L.; Zhang, H.; Meldrum, D. R. Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosis. J. Surg. Res. 168:e51–e59; 2011
2. Bi, B.; Schmitt, R.; Israilova, M.; Nishio, H.; Cantley, L. G. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 18:2486–2496; 2007
3. Breitbach, M.; Bostani, T.; Roell, W.; Xia, Y.; Dewald, O.; Nygren, J. M.; Fries, J. W.; Tiemann, K.; Bohlen, H.; Hescheler, J.; Welz, A.; Bloch, W.; Jacobsen, S. E.; Fleischmann, B. K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362–1369; 2007
4. Bruno, S.; Grange, C.; Deregibus, M. C.; Calogero, R. A.; Saviozzi, S.; Collino, F.; Morando, L.; Busca, A.; Falda, M.; Bussolati, B.; Tetta, C.; Camussi, G. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J. Am. Soc. Nephrol. 20:1053–1067; 2009
5. Caldas, H. C.; Fernandes, I. M.; Gerbi, F.; Souza, A. C.; Baptista, M. A.; Ramalho, H. J.; Kawasaki-Oyama, R. S.; Goloni-Bertollo, E. M.; Pavarino-Bertelli, E. C.; Braile, D. M.; Abbud-Filho, M. Effect of whole bone marrow cell infusion in the progression of experimental chronic renal failure. Transplant. Proc. 40:853–855; 2008
6. Camussi, G.; Deregibus, M. C.; Bruno, S.; Cantaluppi, V.; Biancone, L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78:838–848; 2010
7. Cavaglieri, R. C.; Martini, D.; Sogayar, M. C.; Noronha, I. L. Mesenchymal stem cells delivered at the subcapsule of the kidney ameliorate renal disease in the rat remnant kidney model. Transplant. Proc. 41:947–951; 2009
8. Chiurchiu, C.; Remuzzi, G.; Ruggenenti, P. Angiotensinconverting enzyme inhibition and renal protection in nondiabetic patients: The data of the meta-analyses. J. Am. Soc. Nephrol. 16:s58–63; 2005
9. Choi, S. J.; Kim, J. K.; Hwang, S. D. Mesenchymal stem cell therapy for chronic renal failure. Expert. Opin. Biol. Ther. 10:1217–1226; 2010
10. Docherty, N. G.; O’Sullivan, O. E.; Healy, D. A.; Fitzpatrick, J. M.; Watson, R. W. Evidence that inhibition of tubular cell apoptosis protects against renal damage and development of fibrosis following ureteric obstruction. Am. J. Physiol. Renal Physiol. 290:F4–F13; 2006
11. Flaquer, M.; Romagnani, P.; Cruzado, J. M. Growth factors and renal regeneration. Nefrologia 30(4):385–393; 2010
12. Foudah, D.; Redaelli, S.; Donzelli, E.; Bentivegna, A.; Miloso, M.; Dalprà, L.; Tredici, G. Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res. 17:1025–1039; 2009
13. Gatti, S.; Bruno, S.; Deregibus, M. C.; Sordi, A.; Cantaluppi, V.; Tetta, C.; Camussi, G. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol. Dial. Transplant. 26:1474–1483; 2011
14. Gheisari, Y.; Ahmadbeigi, N.; Naderi, M.; Nassiri, S. M.; Nadri, S.; Soleimani, M. Stem cell-conditioned medium does not protect against kidney failure. Cell Biol. Int. 35:209–213; 2011
15. Humphreys, B. D.; Bonventre, J. V. Mesenchymal stem cells in acute kidney injury. Annu. Rev. Med. 59: 311–325; 2008
16. Imai, N.; Kaur, T. Rosenberg, M. E.; Gupta, S. Cellular therapy of kidney diseases. Semin. Dial. 22:629–635; 2009
17. Jeong, J. O.; Han, J. W.; Kim, J. M.; Cho, H. J.; Park, C.; Lee, N.; Kim, D. W.; Yoon, Y. S. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ. Res. 108:1340–1347; 2011
18. Klahr, S.; Morrissey, J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. 283:F861–F875; 2002
19. Kunter, U.; Rong, S.; Boor, P.; Eitner, F.; Muller-Newen, G.; Djuric, Z.; van Roeyen, C. R.; Konieczny, A.; Ostendorf, T.; Villa, L.; Milovanceva-Popovska, M.; Kerjaschki, D.; Floege, J. Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J. Am. Soc. Nephrol. 18:1754–1764; 2007
20. Lai, R. C.; Arslan, F.; Lee, M. M.; Sze, N. S.; Choo, A.; Chen, T. S.; Salto-Tellez, M.; Timmers, L.; Lee, C. N.; El Oakley, R. M.; Pasterkamp, G.; de Kleijn, D. P.; Lim, S. K. Exosome secreted by MSC reduces myocardial ischemia/ reperfusion injury. Stem Cell Res. 4:214–222; 2010
21. La Manna, G.; Bianchi, F.; Cappuccilli, M.; Cenacchi, G.; Tarantino, L.; Pasquinelli, G.; Valente, S.; Della Bella, E.; Cantoni, S.; Claudia, C.; Neri, F.; Tsivian, M.; Nardo, B.; Ventura, C.; Stefoni, S. Mesenchymal stem cells in renal function recovery after acute kidney injury. Use of a differentiating agent in a rat model. Cell Transplant. 20(8):1193–208; 2011
22. Lee, S. R.; Lee, S. H.; Moon, J. Y.; Park, J. Y.; Lee, D.; Lim, S. J.; Jeong, K. H.; Park, J. K.; Lee, T. W.; Ihm, C. G. Repeated administration of bone marrow-derived mesenchymal stem cells improved the protective effects on a remnant kidney model. Ren. Fail. 32: 840–848;2010
23. Mackensen-Haen, S.; Bader, R.; Grund, K. E.; Bohle, A. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin. Nephrol. 15:167–171; 1981
24. Nagle, R. B.; Bulger, R. E.; Cutler, R. E.; Jervis, H. R.; Benditt, E. P. Unilateral obstructive nephropathy in the rabbit: Early morphologic, physiologic, and histochemical changes. Lab. Invest. 28:456–467; 1973
25. Reis, L. A.; Borges, F. T.; Simões, M. J.; Borges, A. A.; Sinigaglia-Coimbra, R.; Schor, N. Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats. Plos One 7(9):e44092; 2012
26. Seikaly, M. G.; Ho, P. L.; Emmett, L.; Fine, R. N.; Tejani, A. Chronic renal insufficiency in children: The 2001 annual report of the NAPRTCS. Pediatr. Nephrol. 18:796–804; 2003
27. Sharma, A. K.; Mauer, S. M.; Kim, Y.; Michael, A. F. Interstitial fibrosis in obstructive nephropathy. Kidney Int. 44:774–788; 1993
28. Timmers, L.; Lim, S. K.; Hoefer, I. E.; Arslan, F.; Lai, R. C.; van Oorschot, A. A.; Goumans, M. J.; Strijder, C.; Sze, S. K.; Choo, A.; Piek, J. J.; Doevendans, P. A.; Pasterkamp G.; de Kleijn, D. P. Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction. Stem Cell Res. 6:206–214; 2011
29. van Koppen, A.; Joles, J. A.; van Balkom, B. W.; Lim S. K.; de Kleijn, D.; Giles, R. H.; Verhaar, M. C. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. Plos One 7(6):e38746; 2012
30. Vaughan, E. D.; Marion, D.; Poppas, D. P.; Felsen, D. Pathophysiology of unilateral ureteral obstruction: Studies from Charlottesville to New York. J. Urol. 172:2563–2569; 2004
31. Villanueva, S.; Ewertz, E.; Carrión, F.; Tapia, A.; Vergara, C.; Céspedes, C.; Sáez, P. J.; Luz, P.; Irarrázabal, C.; Carreño, J. E.; Figueroa, F.; Vio, C. P. Mesenchymal stem cell injection ameliorates chronic renal failure in a rat model. Clin. Sci. (Lond.) 121:489–499; 2011
32. Weiner, D. E.; Tighiouart, H.; Amin, M. G.; Starkm P. C.; MacLeod, B.; Griffith, J. L.; Salem, D. N.; Levey, A. S.; Sarnak, M. J. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J. Am. Soc. Nephrol. 15(5):1307–1315; 2004
33. Xin, H.; Li, Y.; Cui, Y.; Yang, J. J.; Zhang, Z. G.; Chopp, M. Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J. Cereb. Blood Flow Metab. 33(11):1711–1715; 2013
34. Zhou, Y.; Xu, H.; Xu, W.; Wang, B.; Wu, H.; Tao, Y.; Zhang, B.; Wang, M.; Mao, F.; Yan, Y.; Gao, S.; Gu, H.; Zhu, W.; Qian, H. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res. Ther. 4(2):34; 2013
35. Zhu, Y. G.; Feng, X. M.; Abbott, J.; Fang, X. H.; Hao, Q.; Monsel, A.; Qu, J. M.; Matthay, M. A.; Lee, J. W. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 32(1):116–125; 2014.